How is BPC-157 administered?
This describes how BPC-157 is typically administered in clinical and research references, not a self-administration guide. The usual route is Subcutaneous (oral for gut), on a daily schedule, generally over 4-6 weeks on, 4 weeks off. Specific dosing is individual and beyond general information, and human evidence for BPC-157 is limited.
Administration at a glance (reference data)
- Route: Subcutaneous (oral for gut)
- Schedule: Daily
- Cycle length: 4-6 weeks on, 4 weeks off
- Half-life: ~4 hours sub-q
References
- Stable gastric pentadecapeptide BPC 157, review of pharmacology — Sikiric P. et al., Curr Pharm Des, 2018
- Pentadecapeptide BPC 157 effects on rat tendon healing — Krivic A. et al., J Orthop Res, 2006
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on BPC-157
Last updated 2026-06-15.